Australia markets closed

Dermapharm Holding SE (DMP.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
36.70+0.20 (+0.55%)
At close: 05:35PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 1.94B
Enterprise value 2.86B
Trailing P/E 31.64
Forward P/E 16.45
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.74
Price/book (mrq)3.66
Enterprise value/revenue 2.52
Enterprise value/EBITDA 10.79

Trading information

Stock price history

Beta (5Y monthly) 1.05
52-week change 3-22.77%
S&P500 52-week change 323.49%
52-week high 349.48
52-week low 330.80
50-day moving average 333.95
200-day moving average 338.35

Share statistics

Avg vol (3-month) 326.84k
Avg vol (10-day) 326.57k
Shares outstanding 553.84M
Implied shares outstanding 654.29M
Float 817.39M
% held by insiders 167.74%
% held by institutions 118.14%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.88
Forward annual dividend yield 42.40%
Trailing annual dividend rate 30.88
Trailing annual dividend yield 32.41%
5-year average dividend yield 42.56
Payout ratio 490.52%
Dividend date 3N/A
Ex-dividend date 406 June 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 5.01%
Operating margin (ttm)19.03%

Management effectiveness

Return on assets (ttm)5.08%
Return on equity (ttm)9.33%

Income statement

Revenue (ttm)1.13B
Revenue per share (ttm)20.96
Quarterly revenue growth (yoy)-6.60%
Gross profit (ttm)N/A
EBITDA 208.24M
Net income avi to common (ttm)56.58M
Diluted EPS (ttm)1.16
Quarterly earnings growth (yoy)-11.70%

Balance sheet

Total cash (mrq)117.35M
Total cash per share (mrq)2.18
Total debt (mrq)1.03B
Total debt/equity (mrq)175.28%
Current ratio (mrq)1.57
Book value per share (mrq)10.81

Cash flow statement

Operating cash flow (ttm)178.64M
Levered free cash flow (ttm)81.96M